3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
52
Brain Neoplasms
50
Carcinoma, Non-Small-Cell Lung
48
Neoplasm Metastasis
29
Lung Neoplasms
29
Breast Neoplasms
23
Pancreatic Neoplasms
16
Melanoma
15
Carcinoma, Renal Cell
14
Carcinoma, Hepatocellular
13
Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Urinary Bladder Neoplasms
7
Small Cell Lung Carcinoma
7
Colorectal Neoplasms
7
Kidney Neoplasms
5
Liver Neoplasms
4
Glioblastoma
4
Uveal Melanoma
3
Triple Negative Breast Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Prostate Cancer Metastatic
3
NSCLC
3
Meningioma
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Carcinoma, Transitional Cell
3
Adenocarcinoma
3
Interventions
Carboplatin
6
Paclitaxel
4
pembrolizumab
3
durvalumab
3
selpercatinib
2
Pemetrexed
2
Cisplatin
2
taletrectinib
1
sotorasib
1
repotrectinib
1
pralsetinib
1
ceralasertib
1
cemiplimab
1
aflutinib
1
Telescopes
1
Radiosurgery
1
Nivolumab
1
Gemcitabine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Respiratory Tract Neoplasms
×
Radiosurgery
×
1 year
×
Clear all
NCT02984761
2026-02-19
VALOR
VA Office of Research and Development
Phase NA
Recruiting
670 enrolled